Bioequivalence and Bioavailability Forum 06:39 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Dabigatran EMA - product-specific guide [Regulatives / Guidelines]

posted by nobody - 2019-02-14 15:01  - Posting: # 19921
Views: 190

» » » Aren’t you notoriously shouting “It’s the originator, stupid…”?
» » Could you elaborate on this. No clue what this might mean.
»
» See there.

yeah, but you need irony tags in here,don'T you?

» » If you want a duel, choose your weapon
» » :hungry:
»
» Surströmming?

No chemical weapons.

» » » I’m more concerned about the first footnote in the guidance […]. Was the EMA’s PKWP not aware of the the FDA’s guidance?
» »
» » Narrow therapeutic range... maybe in the USA. In the EU there are no mass tort trials...
»
» I don’t like the idea that someone widens the limits for this stuff.

...maybe we will never see such generics in our lifetime. Wait and see...

Kindest regards, nobody

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,188 posts in 4,084 threads, 1,308 registered users;
online 10 (0 registered, 10 guests [including 8 identified bots]).

The aim of science is not to open the door to infinite wisdom,
but to set a limit to infinite error.    Bertolt Brecht

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed